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ABSTRACT
eIF4A is a key component in eukaryotic translation
initiation; however, it has not been clear how auxil-
iary factors like eIF4B and eIF4G stimulate eIF4A
and how this contributes to the initiation process.
Based on results from isothermal titration calorim-
etry, we propose a two-site model for eIF4A binding
to an 83.5kDa eIF4G fragment (eIF4G-MC), with a
high- and a low-affinity site, having binding con-
stants KD of  50 and  1000nM, respectively.
Small angle X-ray scattering analysis shows that
the eIF4G-MC fragment adopts an elongated, well-
defined structure with a maximum dimension of
220A ˚ , able to span the width of the 40S ribosomal
subunit. We establish a stable eIF4A–eIF4B complex
requiring RNA, nucleotide and the eIF4G-MC
fragment, using an in vitro RNA pull-down assay.
The eIF4G-MC fragment does not stably associate
with the eIF4A–eIF4B–RNA-nucleotide complex but
acts catalytically in its formation. Furthermore, we
demonstrate that eIF4B and eIF4G-MC act synergis-
tically in stimulating the ATPase activity of eIF4A.
INTRODUCTION
In eukaryotes, translation initiation relies on spatial and
temporal interactions between many initiation factors;
however, their interaction map is still poorly understood.
Initiation begins with eIF1, eIF1A, and eIF3 stimulated
recruitment of the ternary complex (eIF2–GTP–Met-
tRNAi
Met) to the 40S ribosomal subunit forming the 43S
pre-initiation complex (PIC). The following steps involve
the initiation factor eIF4F that consists of three initiation
factors: the cap-binding protein eIF4E, the archetypical
DEAD-box helicase eIF4A and the large scaffold
protein eIF4G that contains binding sites for the two
other factors. Upon assembly of the 43S PIC, mRNA
bound to eIF4E in the eIF4F complex is recruited to the
43S PIC through interaction with eIF3, forming the 48S
PIC. Next, the search for the AUG start codon begins (the
scanning process) involving eIF1 and eIF1A along with
the eIF4F complex. Recognition of the start codon
triggers the eIF5 stimulated GTPase activity of eIF2,
and the subsequent release of inorganic phosphate (Pi)
irreversibly commits the PIC to initiation at this start
codon. This is followed by the eIF5B-dependent joining
of the 60S ribosomal subunit resulting in a competent 80S
ribosome ready for elongation [for recent reviews, see refs
(1,2)].
Both mammalian and yeast eIF4G contain binding sites
for the poly(A)-binding protein (PABP), eIF4A and
eIF4E, while only mammalian eIF4G contains binding
sites for eIF3 and the Mnk1 kinase. The mammalian
eIF4G has two eIF4A binding domains: one in the
central part and the other in the carboxy-terminal part
of eIF4G (3) (Figure 1A). Mutations in the carboxy-
terminal eIF4A binding domain were found to decrease
48S PIC formation 3- to 4-fold using toe-print analysis;
while mutations in the central eIF4A binding domain
abolished 48S PIC formation (4). Yeast eIF4G has only
a single binding domain for eIF4A (5) that is homologous
to the central part in the mammalian eIF4G (3).
It has been demonstrated that eIF4B stimulates the
ATPase and helicase activities of eIF4A (6–8), in agree-
ment with genetic data from Saccharomyces cerevisiae (9),
and that human eIF4G stimulates the ATPase activity of
eIF4A (10), although the interplay between the factors is
not known. The molecular mechanism behind activation
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Figure 1. Interactions between eIF4A, eIF4B and eIF4G fragments. (A) Schematic representation of the constructs used in this study or mentioned
in the text. Colored bars show motifs expected to be involved in protein–protein interactions (interacting partner indicated) and motifs involved in
dimerization (DRYG) or RNA binding (RRM and ARM). Poly(A) binding protein (PAPB). yeIF4G is the yeast homolog of mammalian eIF4G.
The numbering in parenthesis for yeIF4G and eIF4GII correspond to the amino acid position, while the numbering above refer to the corresponding
position in human eIF4GI based on sequence alignment using Clustal W. (B) Cobalt pull-down experiments using eIF4A-His6 (lanes 1–6) or negative
controls without (lanes 7–10) and the indicated proteins. Proteins eluted using 400mM Imidazole from the TALON beads are shown in the upper gel
(eluted) and 15% of the ﬂow through (FT) is shown in the lower gel. All eIF4A-His6 were bound to the TALON beads. (C) Streptavidin pull-down
experiments using a pU30 biotinylated RNA. All reactions contain eIF4B and eIF4A and where indicated His6-eIF4G-MC, nucleotide analogs or
biotinylated RNA. All reactions were incubated for 1h at 4 C. The upper gel shows the proteins that bound to the RNA (boiled) and the lower gel
shows 15% of the ﬂow through (FT). (D) As in (C) but reactions contain eIF4A, eIF4BC and pU30-biotin along with the indicated amount of
eIF4G-MC and ADP-AlFx as nucleotide analog. Each reaction was incubated at 4 C for the indicated time (min). (E) As in (D) but using ﬁxed
amount of either eIF4G-MC, eIF4G-M or eIF4G-C where indicated. Each reaction was incubated for 1hr at room temperature. The asterisk
indicates the position of the streptavidin moiety eluted by boiling. Due to the similar position of eIF4G-MC and eIF4B on a SDS–PAGE gel,
eIF4BC was used in (B), (D) and (E). Note that eIF4B has a strong nucleotide-independent RNA binding leading to a basal level of eIF4B while
eIF4G-MC has a low nucleotide-independent RNA binding. eIF4A has a low nucleotide-dependent RNA binding.
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model has been proposed for human eIF4G’s stimulation
of eIF4A (11) in which eIF4G stabilizes an eIF4A con-
formation that stimulates its activity. Accordingly, the
crystal structure of the yeast eIF4G–eIF4A complex
demonstrated that eIF4A was kept in a slightly open con-
formation (5) compared to the closed conformation
known from various DEAD-box ATPases bound to
RNA and nucleotide analogs (12–15). In this manner
eIF4G orients the different conserved motifs in eIF4A
so that they are ready to bind RNA and ATP (5). In
this structure eIF4G interacts with both the N-terminal
domain (NTD) and the C-terminal domain (CTD) of
eIF4A. However, the NTD interaction was predicted to
be broken upon binding of RNA and ATP to eIF4A (5),
suggesting that eIF4G does not stably bind the closed
active conformation of eIF4A. A fragment of human
eIF4G (cpcC) that includes the two eIF4A binding sites,
but not the N-terminal part and the eIF4E binding site
(residues 653–1600, see Figure 1A), activated the ATPase
activity of eIF4A to nearly the same extent as eIF4F itself
(10). In fact, eIF4G can replace eIF4F in an in vitro assay
if both eIF4A and eIF4B are present (16). It has also been
demonstrated that there is a dynamic exchange between
free eIF4A and eIF4A incorporated into eIF4F (17,18). It
is therefore advantageous to study the interaction between
eIF4A and eIF4G outside of the context of the eIF4F
complex. Even though eIF4B has been shown to stimulate
the helicase activity of eIF4A, a stable reconstituted
complex between these proteins has never been ﬁrmly
demonstrated. Electrophoretic mobility shift assay has
been the only way to detect the complex to date (19).
Unwinding of double-stranded (ds) nucleic acid or
rearrangement of RNA–protein complexes is required in
virtually all steps of the gene expression pathway
and involves the coordinated action of RNA helicases
(20–23). eIF4A belongs to helicase superfamily 2, and
the helicase activity of eIF4A is believed to be required
to unwind mRNA secondary structure both during the
formation of the 48S PIC and the scanning process. The
involvement of eIF4A has been shown to be related to the
degree of secondary structure in the 50-untranslated region
(50-UTR) of the mRNA and it is required for translation
of mRNAs containing even weak secondary structures in
the 50-UTR (16,24). It was recently demonstrated that the
DEAH/RHA helicase DHX29 is also required for trans-
lation if the 50-UTR of the mRNA is highly structured
(25). The action of DHX29 is not necessarily mediated
by helicase activity acting on the mRNA but instead
could be remodeling of the 48S PIC (25). Another
helicase involved in translation initiation is Ddx3/Ded1
(26,27). It is not clear how or if these three different
helicases function in concert.
The 40S ribosomal subunit does not contain a motor
for the movement along the mRNA during scanning.
Unless diffusion can account for this movement, this
force must be provided by some external factor.
Historically, eIF4A is believed to act as a helicase down-
stream of the ribosome allowing unhindered scanning.
Based on a cryo electron microscopy reconstruction of
the 40S ribosomal subunit in complex with eIF3 and
eIF4G, eIF4G was placed near the exit site (28). This
observation led to the following suggestion (29): eIF4A
is positioned downstream of the 48S PIC, eIF4G makes
contact with mRNA upstream of the scanning 48S PIC,
while these two factors remain in a complex together.
Another recent model for the scanning process (30)
proposed a Brownian ratchet model, where eIF4B
serves as the pawl and eIF4A as the clamp allowing
only forward movement at the trailing edge of the ribo-
somal subunit. Even low-resolution structural informa-
tion of larger fragments of eIF4G could provide
valuable insights into the function of these initiation
factors during the formation of the 48S PIC, as well as
their position relative to the 40S subunit.
We are interested in the interactions between eIF4A,
eIF4B and eIF4G and how these might be integrated in
the scanning process. Using puriﬁed recombinant proteins
for our study, we report on how the activity of eIF4A is
regulated through its interactions with eIF4B and eIF4G.
Furthermore, we report the shape of a large eIF4G
fragment and its complex with eIF4A determined by
small-angle X-ray scattering (SAXS).
MATERIALS AND METHODS
Plasmids and puriﬁcations
eIF4A, eIF4B full length, eIF4BC and eIF4G fragments
were all expressed from pET30Ek/LIC plasmids
(Novagen). DNA constructs were made by Ligation
Independent Cloning using primers listed in
Supplementary Table S1. The 50-primers were modiﬁed
by having the sequence encoding a TEV (tobacco etch
virus) protease recognition site inserted in front of the
open reading frame, allowing proteolytic removal of the
histidine-tag. PCR was performed using DNA encoding
wild-type human eIF4A, eIF4B or eIF4G1 as template,
respectively. To construct eIF4A with a 6xHis tag in the
C-terminus a stop codon (TGA) was mutated to a glycine
(GGA) by site-directed mutagenesis (QuikChange
Lightning, Stratagene) allowing read-through to the
C-terminal histidine tag in the pET30 vector, using the
oligos listed in Supplementary Table S1. All constructs
that involved PCR were sequenced to verify that no muta-
tions were introduced during the PCR. Plasmids were
transformed into the BL21 Rosetta Escherichia coli strain
and cultures were grown at 37 Ct oa nO D 600 of approxi-
mately 0.8 and then induced with 0.5mM IPTG and
incubated over night at 20 C. Cells were harvested by
centrifugation and the cell pellet was resuspended in lysis
buffer containing 20mM Tris–HCl pH 7.6, 500mM KCl,
20mM Imidazole pH 8, 5mM MgCl2, 0.5mM
b-mercaptoethanol (b-ME), 1mM PMSF, Complete
Protease Inhibitor (Roche Diagnostics GmbH) and 10%
glycerol. The cell suspension was sonicated and then
centrifuged at 14000rpm for 30min. The supernatant
was ﬁltered through a 0.45mm ﬁlter prior to loading on a
Ni
2+ charged immobilized metal afﬁnity chromatography
(IMAC) column (GE Healthcare). Bound protein was
eluted from the Ni
2+ afﬁnity column with a 20–500mM
imidazole gradient in lysis buffer without protease
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addition of 1/300 (w/w) His-tagged TEV protease and in-
cubation on ice for 2h followed by dialysis over night
against 20mM Tris–HCl pH 7.6, 500mM KCl, 5mM
MgCl2, 0.5mM b-ME and 10% glycerol, after which the
dialyzed mixture was re-loaded on a Ni
2+ afﬁnity column.
The proteolytic cleavage with TEV leaves a glycine
upstream of the start methionine. The ﬂow through con-
tained essentially pure protein while the TEV protease and
the cleaved tag remained bound to the column. eIF4G-MC
was in some cases further puriﬁed on a Source 15S column
equilibrated in 20mM HEPES pH 6.8, 10% glycerol,
50mM NaCl, 0.5mM dithiotretiol (DTT) and eluted by
increasing the concentration of NaCl to 200mM in a
linear gradient. This resulted in pure protein with an
OD260/OD280 ratio of 0.6 indicating the absence of RNA.
Cobalt afﬁnity pull-down
Cobalt charged TALON beads (TALON Superﬂow, BD
Bioscience) were prepared (20ml of a 50% slurry per
reaction) by washing three times with 50ml buffer A
(150mM NaCl, 20mM Tris–HCl pH 7.6, 5mM MgCl2,
10% glycerol, 0.1% NP40, 0.5mM b-ME) per reaction.
All centrifugation steps were done at 3000rpm for 2min,
after which the Eppendorf tubes containing the beads
were turned 180  and brieﬂy centrifuged again for 3–4s
to allow for more complete removal of the supernatant.
During the last wash, the beads were resuspended in the
number of Eppendorf tubes equal to the number of ex-
periments. After the last centrifugation, the buffer was
removed leaving behind the beads. About 5mg of the
His-tagged protein was used together with a surplus of
the non tagged proteins as indicated and the mixture
was incubated at 4 C for 1h in a total volume of 100ml
buffer A. Where indicated, ADP, AlCl3 and BeSO4 were
added at a ﬁnal concentration of 1mM while NaF was
added to a concentration of 10mM. The protein mixture
and the beads were incubated for 30min at 4 C on a roller.
Following incubation, the beads were gently pelleted and
15ml supernatant was removed as ‘ﬂow through’. This was
followed by three washes of 100ml ice cold buffer A. After
the last wash the supernatant was carefully removed and
the beads were resuspended in 17ml buffer A containing
400mM Imidazole to elute bound protein. After incuba-
tion for 10–15min at 4 C, the beads were pelleted by cen-
trifugation at 13.4k rpm for 1min and 15ml supernatant
containing the bound protein were removed as ‘Eluted’.
SDS–PAGE loading buffer was added to samples, which
were boiled for 3min and analyzed by SDS–PAGE.
Coomassie blue staining was used to visualize the
protein after electrophoresis.
Biotin-RNA pull-down
For RNA pull-down 20ml of a 50% slurry of High-
Capacity Streptavidin agarose Resin (Thermo Scientiﬁc)
and 100pmol of pU30-biotin (Dharmacon) were used per
reaction. All centrifugation steps were done as described
above. Prior to experiments the beads were washed three
times in buffer B (20mM Tris–HCl pH 7.6, 150mM NaCl,
5mM MgCl2, 1mM DTT). All components in the RNA
pull-down (protein, nucleotide, analogs and biotinylated
RNA) were mixed in a total volume of 100ml of buffer B
and incubated for the indicated times on a roller. Where
indicated ADP, AlCl3, NaF and BeSO4 were added as
described above. Following incubation the beads were
gently pelleted and 15ml solution was removed as ‘ﬂow
through’. The beads were washed three times using
100ml buffer B. After the last centrifugation, supernatant
was removed as much as possible and due to the extreme
afﬁnity of streptavidin for biotin, we eluted the bound
protein by boiling the beads with 15ml 2.5 SDS
loading buffer. The samples were boiled for 3min and
analyzed by SDS–PAGE. Coomassie blue staining was
used to visualize the protein after electrophoresis. The
boiling of the beads resulted in a more pronounced back-
ground binding to the beads in RNA pull-down
experiments.
ATPase assay
ATPase activity was monitored by quantifying the
released Pi according to Baginsky (31) in an assay
optimized for a plate reader (Victor
3, Perkin Elmer) and
96-wells plates. Each reaction contained 45ml assay buffer
B with the indicated proteins and poly(U) (Sigma) [1mg
p(U)/1mg eIF4A] and was started by the addition of 5ml
30mM ATP. The plate was incubated at RT for 60min,
after which the color was developed by adding 50ml
freshly made solution prepared by mixing 25ml
(170mM ascorbic acid, 0.5 M HCl, 0.1% SDS) and 5ml
(28mM ammonium heptamolybdate). Both of these solu-
tions were prepared in advance and placed on ice for at
least 1h. After incubation for 10min, 75ml stop solution
(154mM Sodium Meta arsenic, 86mM trisodium citrate,
2% acetic acid) was added. After 30min the color was
stable and the absorption at =860nm was measured
using the plate reader.
SAXS
The eIF4A-4G complex was isolated by gel ﬁltration chro-
matography with a Superdex 200 10/300 GL column
(GE healthcare) equilibrated in buffer C (20mM Tris–
HCl pH 7.6, 150mM NaCl, 5mM MgCl2, 1mM EDTA,
1mM DTT) and the complex was concentrated to 5mg/ml.
The SAXS measurements were carriedout onalaboratory-
basedinstrumentatAarhusUniversity (32).Measurements
were done at concentrations c and c/2 for 3h each at 4 C.
Background subtraction and all necessary normaliza-
tions were carried out with the SUPERSAXS package
(Oliveira,C.L.P. and Pedersen,J.S., unpublished data).
The data were normalized to absolute scale by use of
waterasaprimarystandard.Theﬁnalintensityisdisplayed
as a function of the modulus of the scattering vector,
q=4p sin/l, where l=1.54A ˚ and is the X-ray wave-
length and 2 is the angle between the incoming and scat-
tered X-rays. Indirect Fourier Transformation (IFT) was
performed (33) implemented in a home-written program
(34) (Oliveira, C.L.P. and Pedersen,J.S., unpublished
data). The ab initio modeling was carried out using the
program DAMMIN (35) that uses a search space ﬁlled
with close-packed spheres, regarded as dummy atoms.
Nucleic Acids Research,2011, Vol.39, No. 7 2681Usingasimulated annealingtechniqueandconstraints that
gives globular protein-like structures, the subset of dummy
atoms that gives the best ﬁt of the experimental data is
obtained. Owing to the Monte Carlo nature of the opti-
mization procedure, the generated models are not unique.
Thus in order to obtain the most probable shape, 10 indi-
vidual runs were performed, and compared and averaged
using the DAMAVER program package (36).
Isothermal titration calorimetry
Prior to isothermal titration calorimetry (ITC) analysis
proteins were dialyzed overnight against buffer C and
their concentrations were determined by total amino
acid analysis. The protein solutions were degassed using
a MicroCal ThermoVac with stirring prior to the experi-
ment. The ITC measurements were carried out on a
Microcal VP-ITC instrument at 30 C. The reference
power was set at  15mcal/s and the stirrer at 312rpm.
All handling of the Microcal VP-ITC and ThermoVac
was done according to manufacturer’s user manual.
Surface plasmon resonance
Surface plasmon resonance (SPR) experiments were
carried out on a Biacore T100 instrument at 25 C using a
Series S Sensor Chip NTA Certiﬁed (Biocore AB) allowing
binding of His-tagged proteins. The preprogrammed
NI-Kin method was used with the modiﬁcation that both
channels were injected with running buffer [10 mM HEPES
pH 7.4, 150mM NaCl, 50mM EDTA, 0.05% Tween-20,
0.1% BSA (Sigma)] containing 0.5mM NiCl2.
Regeneration of the chip was performed after each meas-
urement according to the NI-Kin method program [10 mM
HEPES pH 8.3, 150mM NaCl, 350mM EDTA, 0.05%
Tween-20, 0.1% BSA (Sigma)]. Buffers were ﬁltrated
using a 0.22mm ﬁlter (Advantec) before use. The SPR
experiments were done according to manufacturer’s user
manual.
RESULTS
Complex formation between eIF4A and eIF4G-MC
To investigate the interaction between eIF4A and three
eIF4G fragments, eIF4G-MC, eIF4G-M or eIF4G-C
and the C-terminal truncated eIF4B (eIF4BC)
(Figure 1A), a cobalt afﬁnity pull-down was employed
using C-terminal His-tagged eIF4A (eIF4A-His6). The
pull-down experiments were carried out in the absence
of nucleotide and RNA. eIF4BC was used in the
cobalt afﬁnity experiments since full-length eIF4B
migrates at nearly the same position as eIF4G-MC on
an SDS–PAGE gel, and is more prone to degradation,
but otherwise appears to behave similarly to eIF4BC
with respect to complex formation with eIF4A (see
below). eIF4A-His6 formed a stable complex with either
eIF4G-MC or eIF4G-M (Figure 1B, lanes 2 and 4),
while only a very weak interaction was detected with
eIF4G-C and no interaction was detected with
eIF4BC, (Figure 1B, lanes 3 and 5). Interestingly, if
both eIF4G-MC and eIF4BC were added together, the
interaction between eIF4A and eIF4G-MC remained
intact; however, eIF4BC could now also be detected
(Figure 1B, lane 6). eIF4BC could also be detected in
a pull-down experiment with eIF4A-His6 in the presence
of eIF4G-M, however eIF4G-C did not support eIF4BC
interaction (data not shown). Control reactions without
eIF4A-His6 in the pull-down experiments were negative
(Figure 1B, lanes 7–10).
To further investigate the interaction between eIF4A
and eIF4G-MC, ITC and SPR were used. In an ITC
experiment with eIF4A being added to eIF4G-MC in the
chamber, the best ﬁt obtained was with a two-site binding
model, suggesting a high-afﬁnity site (KD=50±15nm)
[standard deviation (n=4)] and a low-afﬁnity site
(KD=775±181nM) [standard deviation (n=4)]
(Figure 2A, left panel displays a representative experi-
ment). Performing the ITC experiment in reverse, with
eIF4G-MC being added to eIF4A in the chamber, gave
similar results, KD 42nM for the high-afﬁnity site and
1.6mM for the low-afﬁnity site (data not shown). SPR
results, with immobilized eIF4G-MC and eIF4A as
analyte, could also be ﬁtted to a heterologous two-state
binding model characterized by a high-afﬁnity site
(KD 67nM) and a low-afﬁnity site (KD 1.5mM)
(Figure 2B). To investigate the location of the high-afﬁnity
site we mutated the conserved phenylalanine 978 to alanine
in eIF4G-MC. This mutant has previously been shown
to affect binding between eIF4A and the middle region
of eIF4G containing the high-afﬁnity site (4,29). In
the yeast structure, Phe 838 (equivalent to 978 in
human eIF4GI) ﬁts into a hydrophobic groove formed
by four residues from eIF4A (5). ITC data obtained by
adding eIF4A to eIF4G-MC (F978A) in the chamber was
best ﬁtted to a 1:1 binding model (KD=417±41nM)
[standard deviation (n=2)], suggesting that the F978A
mutant disrupted the high-afﬁnity binding site
(Figure 2A, right panel displays a representative
experiment).
SAXS investigation of the complex between eIF4A and
eIF4G-MC
The complex between eIF4A and eIF4G-MC
demonstrated by cobalt afﬁnity pull-down could also be
isolated by gel ﬁltration chromatography performed in
the absence of RNA and nucleotide (Supplementary
Figure S1). SAXS analysis was used to determine the
overall shape of the complex puriﬁed in this manner.
The scattering curves were measured for the complex
between eIF4A and eIF4G-MC and for eIF4G-MC
alone (Figure 3A). Indirect Fourier Transformation
(IFT) was used for determining the pair distance distribu-
tion function p(r) that is a histogram of distances between
pair of points within the complexes and thus gives infor-
mation on particle shape and maximum particle diameter
(Figure 3B). By comparison with p(r) functions of known
structures (37), it was concluded that the particles have
an elongated shape. The p(r) functions approach zero at
the maximum diameter, which is around 200–220A ˚ for
both particles. Ab initio shape determination was carried
out and averaged ﬁnal models were derived, each based on
2682 Nucleic Acids Research, 2011,Vol.39, No. 710 individual runs. The resulting model of eIF4G-MC by
itself displays an elongated shape with a distinct 130  bend
near the middle (Figure 3D). The model of the complex
between eIF4A and eIF4G-MC was qualitatively similar
but indicated extra mass located preferentially to one side
of the bend, which we believe may represent eIF4A in the
complex (Figure 3E). The mass of the eIF4A and eIF4G-
MC complex calculated from the SAXS data suggested a
1:1 complex. Densitometric analysis (Supplementary
Figure S1) also indicated a 1:1 complex. Overall, the
molecular shape revealed by SAXS most likely represents
one molecule of eIF4A bound to the high-afﬁnity site of
eIF4G-MC, while eIF4A bound to the low-afﬁnity site
dissociates due to the dilution during the gel ﬁltration.
The crystal structures of two fragments of mammalian
eIF4G overlapping with our eIF4G-MC fragment have
previously been determined (Figure 1A). The so-called
middle fragment of eIF4GII (corresponding to residues
752–1010 within our eIF4G-MC fragment of eIF4GI)
contains a high-afﬁnity eIF4A binding site (38). A
C-terminal fragment of eIF4GI consisting of residues
1235–1572 contains a low-afﬁnity eIF4A binding site
and a Mnk1 kinase site (39). These two eIF4G fragments
consist, nearly exclusively, of a-helical HEAT repeats
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ing eIF4G were unstructured (29,39). Accordingly,
residues 1011–1234 in our eIF4G-MC fragment, which
are not covered by any of the two a-helical fragments,
might be unstructured. However, since the ab initio
models ﬁt the SAXS data very well out to the highest
scattering vector q (Figure 3C), this indicates that this
portion of eIF4G is not unstructured and ﬂexible. To in-
vestigate the secondary structure of the eIF4G-MC
fragment, we performed synchrotron circular dichroism
(CD) measurements. Taking into account that the
known portions of eIF4G-MC do not contain any
b-sheets, our CD measurements suggest that approximate-
ly 50% of the residues 1011–1234 are folded into b-sheets
(Supplementary Figure S2), supporting a well-deﬁned con-
formation of these residues, in accordance with our SAXS
analysis.
Complex formation between eIF4B and eIF4A is
promoted by eIF4G-MC
The cobalt afﬁnity pull-down experiments described above
were performed in the absence of RNA and nucleotide; to
investigate the effects of RNA and nucleotide we per-
formed streptavidin–agarose pull-down assays utilizing a
biotinylated 30mer uracil RNA. Using this assay a stable
complex was detected between eIF4A and eIF4B in
a reaction containing ADP-AlFx and eIF4G-MC
(Figure 1C, lane 1). ADP-AlFx is an analog that resembles
the transition state during ATP hydrolysis in DEAD-box
ATPases (14). No eIF4A–eIF4B complex was detected in
the absence of either eIF4G-MC (Figure 1C, lane 3) or
ADP-AlFx (Figure 1C, lane 4), only eIF4B was bound to
RNA in these reactions most likely through its two RNA
binding motifs. In the absence of biotinylated RNA
(Figure 1C, lane 2) only a weak non-speciﬁc binding of
eIF4B was detected. Interestingly, even though
eIF4G-MC was required for the formation of the
eIF4A–eIF4B–RNA–ADP–AlFx complex, it was not
present in the complex (Figure 1C–E). We reasoned that
eIF4G might be acting catalytically in the formation of the
eIF4A–eIF4B–RNA–ADP–AlFx complex. This idea was
tested by comparing the amount of eIF4A–eIF4BC
complex formed after 15min incubation, with approxi-
mately stoichiometric amount of eIF4G-MC present
(Figure 1D, lane 1) to the amount of eIF4A–eIF4BC
complex formed after 15, 60 and 240min incubation
with a 30-fold lower concentration of eIF4G-MC
(Figure 1D, lanes 2–4). The build-up of eIF4A–
eIF4BC complex over time strongly indicated the cata-
lytic effect of eIF4G-MC (Figure 1D, lanes 2–4). As
controls, either eIF4G-MC or the nucleotide was
omitted from the reaction (Figure 1D, lanes 5 and 6).
Full-length eIF4B also formed a complex with RNA, nu-
cleotide and eIF4A that was dependent on eIF4G-MC
(Supplementary Figure S3A); however, the complex was
not formed as efﬁciently as with eIF4BC. The eIF4A–
eIF4BC complex can be formed with both an ATP
analog (ADP–BeF3) and a transition state analog
A B
C
E
D eIF4G-MC
eIF4A-eIF4G-MC G-MC
~130°
~130°
90°
90°
Figure 3. SAXS analysis of the complex between eIF4A and eIF4G-MC and eIF4G-MC alone. (A) Indirect Fourier transformation (IFT) ﬁts of the
scattering data for eIF4G-MC (red) and the complex between eIF4A and eIF4G-MC (black). (B) Pair distances distribution functions from the IFT
ﬁtting in (A) with functions scaled for comparison. (C) Fits to the scattering data for the ab initio shape determination with DAMMIN. (D) Ab initio
model of eIF4G-MC. (E) Ab initio model of the complex between eIF4A and eIF4G-MC.
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and to a lesser degree with ADPNP (data not shown) but
not with ADP, AlFx, BeF3 or NaF alone (Supplementary
Figure S3B and data not shown). Furthermore, the
eIF4A–eIF4BC–RNA–ADP–BeF3 complex was stable
enough to be puriﬁed on an ion exchange column while
no complex was formed if RNA was omitted
(Supplementary Figure S4). Importantly, in the experi-
ment in Supplementary Figure S4, which contained
poly(U) as RNA, the complex was treated with RNase
A prior to ion exchange chromatography, strongly sug-
gesting that eIF4A and eIF4B interact directly. To inves-
tigate if both eIF4A-binding domains in eIF4G were
required for eIF4A–eIF4B complex formation, RNA
pull-downs using either eIF4G-MC, eIF4G-M or
eIF4G-C with eIF4A, eIF4BC and ADP-AlFx were
carried out. An eIF4A–eIF4BC complex could only be
identiﬁed using eIF4G-MC (Figure 1E).
The complex between eIF4A and eIF4BC was also
isolated using cobalt afﬁnity pull-down in the presence
of a His-tagged eIF4A, eIF4BC, eIF4G-MC, a U25
oligo and ADP–BeF3 (Supplementary Figure S3C, lane 2),
but the complex was absent when eIF4G-MC was not
added (Supplementary Figure S3C, lane 3). We used a
25 mer uracil oligo since an RNA of this length most
likely will not accommodate binding of both eIF4A and
eIF4B independently. Concomitant with eIF4A–eIF4BC
complex formation, a reduction in the amount of eIF4G-
MC isolated in complex with eIF4A was apparent
(Supplementary Figure S3C, compare lanes 1 and 2 in
the upper panel). The ﬂow-through contained more
eIF4G-MC and less eIF4BC as expected when eIF4A
formed a complex with eIF4BC (Supplementary
Figure S3C, compare lanes 1 and 2 in the lower panel).
Synergistic activation of the ATPase activity of eIF4A
requires eIF4B and eIF4G-MC
Based on the data presented above we hypothesized
that eIF4B and eIF4G-MC synergistically stimulate the
ATPase activity of eIF4A. A Baginsky ATPase assay
(31), modiﬁed for a plate reader that measures the
amount of inorganic phosphate produced when ATP is
hydrolyzed, was used to test this hypothesis. The ATPase
activity of eIF4A could be stimulated by poly(U),
as expected for an RNA dependent ATPase (Figure 4A,
reactions 1 and 2). Under the experimental conditions
used, near stoichiometric amounts of eIF4B had no
effect (Figure 4A, reaction 3) whereas eIF4G-MC in
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reproducibly, enhanced the ATPase activity (Figure 4A,
reaction 4). However, when both eIF4B and eIF4G-MC
were present, more than 3-fold stimulation was observed
(Figure 4A, reaction5). Increasing the amount of eIF4A by
2-fold nearly doubled the activity (Figure 4A, reaction 6),
suggesting that eIF4A is the only rate-limiting factor. The
activity was dependent on RNA and eIF4A (Figure 4A,
reactions 7 and 8) and the stimulation by eIF4B and
eIF4G-MC was speciﬁc since an unrelated DEAD-box
ATPase, Dbp5, did not respond to these factors but
was stimulated by poly(U) as expected (Figure 4B, reac-
tions 1–3). Only the eIF4G-MC fragment, but not
eIF4G-M or eIF4G-C, led to a synergistic activation of
eIF4A with either eIF4B or eIF4BC (Supplementary
Figure S5). All control reactions were done with the
addition of buffer instead of ATP (Figure 4 and
Supplementary Figure S5). An RNA binding motif of
40 residues, suspected to be involved in scanning (40), is
located just upstream of the eIF4G-MC region. We there-
fore tested whether a longer eIF4G-MC protein containing
residues 682–1451 including this RNA binding motif
would furtherstimulate eIF4A.With respect to stimulation
of the ATPase activity this longer version of eIF4G-MC
gave similar results to those obtained with eIF4G-MC
(data not shown) but this protein did indeed bind the
U30-Biotin two to three times stronger than eIF4G-MC
(data not shown).
DISCUSSION
In order to clarify the role of various regions in mamma-
lian eIF4G, we produced the eIF4G-MC protein delimited
in either end by two well-deﬁned structural domains es-
tablished by structures of smaller human eIF4G fragments
and the structure of yeast eIF4A in complex with a
fragment of yeast eIF4G (5,38,39). A stable complex
between eIF4A and eIF4G-MC, independent of RNA
and nucleotide, was identiﬁed and ITC and SPR analysis
demonstrated a two-site binding model with a low and a
high-afﬁnity site. Furthermore, a stable complex between
eIF4A and eIF4B, dependent on RNA, nucleotide and
catalytic amounts of eIF4G-MC, was also reconstituted.
In agreement with these data, a synergistic stimulation of
eIF4A’s ATPase activity by eIF4B and eIF4G-MC was
established.
The interaction between eIF4A and its two binding
domains in human eIF4GI was demonstrated earlier
(3,4). Using SPR analysis, the so-called middle fragment
[residues 653–1118 of human eIF4GI (cpC3)] and a
C-terminal fragment [residues 1118–1600 of human
eIF4GI (cpC2)] were shown to have KD values of 17 and
330nM, respectively, for their eIF4A complexes (41). Our
data, obtained using either ITC or SPR to characterize the
interaction of eIF4G-MC with eIF4A, were best-ﬁtted
with a two binding site model containing a low- and a
high-afﬁnity site, with the two binding constants in the
same range as identiﬁed earlier in the cpC2 and cpC3
eIF4G fragments (41); (see Figure 1A and Table 1 for
an overview of eIF4G fragments and their corresponding
KD for eIF4A interaction). A shorter fragment of the
middle domain of human eIF4GI [residues 747–993
eIF4G1 (HEAT-1)] has much lower afﬁnity for eIF4A,
KD=12mM (29), suggesting that the binding site may
span a longer region (see Figure 1A and Table 1).
Indeed, weak interaction between eIF4A-CTD and the
eIF4GI CY fragment (spanning residues 994–1138, see
Figure 1A) have been demonstrated by NMR (29). The
CY fragment of eIF4GI is included within the middle
fragment (cpC3) that has a KD of 17nM (41) with the
exception of 20 amino acids (residues 653–1118, see
Figure 1A). This observation suggests that the binding
site for eIF4A-CTD found in the 994–1138 region may
contribute to the nM afﬁnity of the high-afﬁnity site for
eIF4A we measured using the eIF4G-MC fragment
(Figure 2) and that was likewise observed for the middle
binding site of the eIF4GI fragment, cpC3 (41). The stoi-
chiometry of two molecules of eIF4A binding to one
molecule of eIF4G-MC suggested by both our ITC and
SPR experiments is in accordance with earlier results (41).
However, our results conﬂict with data from Fujita and
coworkers which was also obtained using ITC indicating a
1:1 complex (42). The reason for this discrepancy is not
clear, but the concentrations of eIF4A and eIF4G used in
ref. (42) may have been too low to detect a 2:1 complex.
Our results also conﬂicts with data from Li et al. (43) that
used an alternative approach for determining the ratio of
eIF4A:eIF4G. Speciﬁc antibodies against either eIF4AI or
eIF4AII were used to immunoprecipitate protein eluted
from m
7GTP-sepharose incubated with mammalian cell
extracts. This demonstrated that only eIF4AI could be
detected after eIF4AI precipitation and like-wise for
eIF4AII, suggesting that only one eIF4A molecule binds
eIF4G. If two eIF4A molecules bind the same eIF4G
molecule, western blotting of material from immunopre-
cipitation (IP) with eIF4AI antibody should detect eIF4AI
and some eIF4AII and vice versa. The difference in
binding afﬁnity between the two sites could result in
only one eIF4A bound to the high-afﬁnity site after
washing during the IP experiment. However, the same
study suggested that the binding between eIF4A and
either the middle fragment or the C-terminal fragment
of eIF4G were similar (43). The reason for the discrepancy
between our data demonstrating that eIF4G-C has
low-afﬁnity for eIF4A and the data showing that both
eIF4A binding sites are of comparable afﬁnity in IP
experiments (43) is not clear. However, the use of
Table 1. Dissociation constants for the complexes of eIF4A with dif-
ferent fragments of human eIF4GI
Name Amino
acids
High-afﬁnity
site
(nM)
Low-afﬁnity
site
(nM)
Method Reference
eIF4G-MC 712–1451 50 775 ITC This study
eIF4G-MC 712–1451 67 1500 SPR This study
cpC3 653–1118 17 SPR (10)
cpC2 1118–1600 330 SPR (10)
HEAT-1 747–993 12000 SPR (29)
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might mask the low-afﬁnity site by having another com-
ponent stabilizing the complex between eIF4A and the
C-terminal eIF4A binding domain. Alternatively, we
cannot completely rule out that under in vivo like condi-
tions, binding to the high-afﬁnity site may exclude binding
to the low-afﬁnity site, although we in vitro clearly observe
simultaneous binding to both sites. Whatever the reason
for the discrepancy, it is noteworthy that we get the same
qualitative results using very different assays: ITC, SPR
and cobalt afﬁnity pull-down. The consequence of having
two eIF4A molecules bound to eIF4G is not known but it
may induce conformational changes in eIF4G promoting
the recycling of eIF4A and stimulation of eIF4A binding
to eIF4B. If eIF4G in vivo contains two eIF4A binding
sites with KD values of  50 and 1000nM, respectively,
and we further assume eIF4A and eIF4G have cellular
concentrations of 50 and 2mM, respectively, as determined
for the yeast factors (44), then both sites are likely to be
fully occupied.
Our SAXS analysis demonstrated that both eIF4G-MC
and its complex with eIF4A have an elongated structure
with a bend (Figure 3). By comparing our SAXS envelope
for the complex between eIF4A and eIF4G-MC with the
crystal structure of yeast eIF4G in complex with eIF4A (5)
and the structure of the C-terminal fragment of eIF4G
(39), we can propose a qualitative model for the
complex between eIF4A and eIF4G-MC (Figure 5A).
This elongated complex has a length of  220A ˚ , which is
even more remarkable considering that the eIF4G-MC
protein constitutes only about half of the full-length
eIF4G. Such a dimension justiﬁes the description of
eIF4G as a scaffold protein spanning the width of the
40S ribosomal subunit (Figure 5B). eIF4G, bound to the
40S ribosomal subunit through eIF3, most likely has
dimensions that would allow eIF4A to be placed at both
the exit and entry of the mRNA channel of the 40S ribo-
somal subunit. Further research is therefore needed to
address the precise position of eIF4A relative to the
entry and exit sites.
eIF4A and eIF4B cannot replace eIF4F during scanning
in a reconstituted translation initiation system analyzed
using toe-printing, whereas eIF4G could replace eIF4F
if both eIF4A and eIF4B were present (16). This agrees
with our data showing that eIF4G is necessary and sufﬁ-
cient for recruitment of eIF4A into an eIF4A–RNA–
eIF4B-nucleotide complex, and that eIF4B and eIF4G
activate the ATPase activity of eIF4A synergistically. Our
results also suggested a mutually exclusive binding between
eIF4A and either eIF4G or eIF4B, RNA and nucleotide
(Supplementary Figure S3C). This indicates that the
eIF4A–eIF4G complex and the eIF4A–eIF4B–RNA-
nucleotide complex are two separate and consecutive
steps in translation initiation that both are required for
eIF4A function. We therefore propose the following
model for how eIF4B and eIF4G regulate the function
of eIF4A during translation initiation (Figure 5C–F).
Having brought eIF4A to its place of action through
eIF4G (Figure 5C), we suggest that eIF4G induces a con-
formational change of eIF4A preparing it for the inter-
action with eIF4B, ATP and RNA (Figure 5D) as
already suggested by the soft clamp model (11) and the
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Figure 5. Docking of known structural elements of eIF4G in our SAXS envelope and a model for the synergistic activation of eIF4A by eIF4B and
eIF4G. (A) Docking of the structure of yeast eIF4A–eIF4G (PDB entry 2SVO) and the ﬁrst HEAT domain from the structure of the C-terminal
fragment of human eIF4G1 (PDB entry 1UG3) into the SAXS envelope of the complex between eIF4A and eIF4G-MC. (B) Comparison of the size
of the 40S ribosomal subunit [3D EM databank #1376 (46)] and the SAXS envelope of the eIF4A–eIF4G complex. (C–F) Model of eIF4A activation
by eIF4G and eIF4B. (C) The 48 PIC is stalled by a hairpin and eIF4G holds eIF4A in a conformation ready for binding to eIF4B. (D) eIF4B in the
presence of RNA and ATP stimulates the dissociation of the eIF4A–eIF4G complex so that eIF4A can form a complex with eIF4B, RNA and ATP
and induce unwinding after which eIF4A leaves the complex. (E) The PIC moves along the RNA and eIF4G rebinds a molecule of eIF4A. (F)A
second eIF4A binding site may be involved in recruitment of another eIF4A. See ‘Discussion’ section for further details.
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This may also explain the weak stimulation by eIF4G
of the ATPase activity (Figure 4). In vitro RNA is
required for eIF4A–eIF4B complex formation as well
as an ATP analog suggesting that eIF4B also needs to be
in an activated state bound to RNA. In fact, we observe
binding of both eIF4B and eIF4BC to RNA without
concomitant binding of eIF4A (Figure 1C–E). When
the eIF4A–eIF4B–RNA–ATP complex is formed, eIF4B
stimulates the ATPase and helicase activity of eIF4A
(Figure 5D–E). eIF4B may stimulate unwinding solely
by promoting the closed conformation of eIF4A known
from the structure of its paralogue eIF4AIII in complex
with RNA and ATP-analogs (12–14). If true, the
following eIF4B stimulated ATP hydrolysis may only be
required for the release of eIF4A from the RNA as earlier
described for the DEAD-box ATPase Ded1p (45). After
eIF4A dissociates from the mRNA and eIF4B, it may
then rebind eIF4G and be ready for a new round of
unwinding/remodeling (17,18). Whether the low-afﬁnity
eIF4A site functions as a recruitment site for binding to
the high-afﬁnity site or only serves to regulate the binding
of eIF4A to the high-afﬁnity site remains to be settled
(Figure 5E). After unwinding the PIC may now move
further along the mRNA towards the AUG codon
(Figure 5F).
It was demonstrated that eIF4H, as a close homolog of
eIF4B, can partially displace the CTD of eIF4A from the
eIF4GI CY fragment (residues 994–1138) (29), an area
which most likely is contained within the high-afﬁnity
eIF4A binding site in eIF4G-MC (See above). This may
partially explain how eIF4H/eIF4B can induce the dissoci-
ation of eIF4A from eIF4G to allow the assembly of an
eIF4A–eIF4B/4H–RNA-nucleotide complex according to
our model. A compelling question would be whether
eIF4H could also form a complex with eIF4A that
required eIF4G. This may indeed be the case, as we
suggest that the data presented in the Supplementary
Figure S4 by Marintchev et al. (29) could be interpreted
as an eIF4A–eIF4H complex dependent on eIF4G, RNA
and nucleotide but not containing eIF4G, agreeing with
our results, and not as suggested a trimeric eIF4A–
eIF4H–eIF4G complex.
eIF4A has generally been considered the canonical
RNA helicase; however, other models are emerging
where eIF4A does not function as a helicase.
For example, instead of having eIF4A depicted in
Figure 5C–F as a helicase, the model could also have
been adapted to the framework of the ratchet and pawl
model (30) having eIF4A and eIF4B playing a role
upstream instead of downstream of the 40S ribosomal
subunit. Downstream unwinding may also be carried
out by the Dhx29 or Ddx3 helicase. eIF4A on its own is
not a very active enzyme; however, our studies clearly
demonstrate how eIF4G and eIF4B in collaboration can
signiﬁcantly enhance the activity of eIF4A. Our ﬁnding
that eIF4G acts catalytically in the formation of the
complex between eIF4A, RNA, ATP and eIF4B is most
likely crucial for the enzymatic activity of eIF4A during
translation initiation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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